John Fucci
Net worth: 4 500 $ as of 30/07/2026
Net worth: 4 500 $ as of 30/07/2026
John Fucci's current job(s) include being a Partner at BIOS Capital Management LP since 2019 and a Board Member at SIRPant Immunotherapeutics, Inc. since 2021.
His former job(s) include being a Director at Lantern Pharma, Inc. and a Vice President at Steelhead Capital Management LLC from 2016 to 2019.
Mr. Fucci completed his undergraduate degree at Texas Christian University in 2014.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Rein Therapeutics, Inc.
Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs 0.01% | 12/05/2026 | 6,106 ( 0.01% ) | 4 500 $ | 30/07/2026 |
| Companies | Position | Start |
|---|---|---|
BIOS Capital Management LP
BIOS Capital Management LP Investment ManagersFinance BIOS Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and medical device sectors. It provides financing for early and later stage capital requirements. | Private Equity Investor | 30/04/2014 |
SIRPant Immunotherapeutics, Inc.
SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Director/Board Member | 31/10/2021 |
| Companies | Position | End |
|---|---|---|
| LANTERN PHARMA INC. | Director/Board Member | 24/11/2019 |
Steelhead Capital Management LLC
Steelhead Capital Management LLC Investment ManagersFinance Acts as an alternative investment manager | Private Equity Analyst | 01/06/2019 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Texas Christian University
Texas Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Steelhead Capital Management LLC
Steelhead Capital Management LLC Investment ManagersFinance Acts as an alternative investment manager | Finance |
BIOS Capital Management LP
BIOS Capital Management LP Investment ManagersFinance BIOS Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and medical device sectors. It provides financing for early and later stage capital requirements. | Finance |
Lantern Pharma, Inc.
Lantern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drug from advanced genomics and artificial intelligence | Health Technology |
SIRPant Immunotherapeutics, Inc.
SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Health Technology |
Select your edition
All financial news and data tailored to specific country editions